OAM
TMDX icon

Oxford Asset Management’s Transmedics TMDX Stock Holding History

Oxford Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-43,320
Closed -$1.03M – 2089
2019
Q3 		$1.03M Sell
43,320
-70,326
-62% -$1.69M 0.02% 932
2019
Q2 		$3.29M Buy
+113,646
New +$3.1M 0.07% 417

Other funds holding TMDX

ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Oxford Asset Management's TMDX Position: Q4 2019 in Review

Oxford Asset Management sold out of Transmedics (TMDX) in Q4 2019, closing a stake of 43,320 shares — an estimated $1.03M sold.

Oxford Asset Management first reported a position in TMDX in Q2 2019 and held it in 2 quarters. The position peaked at $3.29M in Q2 2019. 60 funds tracked by Wall St. Rank hold TMDX as of Q4 2019.

  • Oxford Asset Management reported no remaining Transmedics position as of Q4 2019 after selling out during the quarter.
  • Oxford Asset Management sold 43,320 Transmedics shares in Q4 2019, an estimated $1.03M.
  • Oxford Asset Management first reported a position in Transmedics in Q2 2019 and held it in 2 quarters.
  • Oxford Asset Management's Transmedics position peaked at $3.29M in Q2 2019.
  • 60 funds tracked by Wall St. Rank held Transmedics as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.